Boron Neutron Capture Therapy of Brain Tumors: Targeting Strategies and Therapeutic Models. Final Progress Report for February 1, 2003 - July 31, 2003
- The Ohio State University, Department of Pathology
The overall goal of this project was to evaluate either boronated EGF or anti-EGFR monoclonal antibodies (MoAbs) as delivery agents for boron neutron capture therapy (BNCT).
- Research Organization:
- The Ohio State University Research Foundation (US)
- Sponsoring Organization:
- USDOE Office of Energy Research (ER) (US)
- DOE Contract Number:
- FG02-98ER62595
- OSTI ID:
- 825198
- Country of Publication:
- United States
- Language:
- English
Similar Records
Evaluation of boronated EGF as a potential delivery agent for BNCT of brain tumors
Boron-neutron capture therapy
Neutron capture therapy
Conference
·
Mon Dec 30 23:00:00 EST 1996
·
OSTI ID:539879
Boron-neutron capture therapy
Book
·
Wed Dec 31 23:00:00 EST 1986
·
OSTI ID:5721278
Neutron capture therapy
Book
·
Wed Dec 31 23:00:00 EST 1986
·
OSTI ID:5604066